Sells health insurance to individuals on the Affordable Care Act marketplaces.
$31.89close as of 2026-10-16
+51.6% over 1Y · 34.9 points ahead of the S&P 500
OSCRS&P 500 (SPY), rebased to OSCR's first close
“Can Oscar sustain its improved medical loss ratio without the same benefit from favorable reserve revisions?”
Editorial note · updated 2026-10-08
The TenQ Radar
Oscar Health in 36 checks
Oscar Health on the TenQ Radar: value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.
A mixed picture, with strengths and real weaknesses: 17 of 36 checks passed.
The Oscar Health story
What drives Oscar Health, what its price assumes and what could change the story, written from its own filings.
Individual coverage leads. After exiting small group plans and the Cigna+Oscar partnership, Oscar reached 2,963,002 effectuated members as of June 30, 2026, versus 2,027,148 a year earlier.
Reserves helped profitability. In the quarter to June 2026, the medical loss ratio improved to 79.2% from 91.1%, reflecting disciplined pricing and $164 million of favorable prior period reserve development.
Cash needs context. Oscar's $4.4 billion of free cash flow over the last twelve months is not an earnings measure for an insurer, so TenQ does not infer growth expectations from it.
Q2 '26 · quarter to 30 June 2026 · reported 6 August 2026 · Earnings release ↗
Revenue$4.9B+70%vs 2025+5.0%vs Q1
Earnings$362M+$590Mvs 2025-47%vs Q1
What the release says
Highlights
Oscar Health reported record profitability for the first half of 2026, with net income attributable to Oscar Health, Inc. of $361.8 million for Q2 2026 compared to a net loss of $228.4 million in Q2 2025, driven by higher membership, rate increases, and favorable prior period reserve development.
The company’s medical loss ratio (MLR) improved significantly to 79.2% in Q2 2026 from 91.1% in Q2 2025, primarily due to disciplined pricing and $164 million of favorable prior period reserve development.
Effectuated membership grew to 2,963,002 as of June 30, 2026, up from 2,027,148 a year earlier, reflecting strong growth in the individual and small group segment after the discontinuation of small group plans and the end of the Cigna+Oscar partnership.
What management expects
Oscar Health raised its full-year 2026 outlook for earnings from operations to a range of $500 million to $700 million, up from the prior range of $250 million to $450 million.
The company now expects a full-year 2026 medical loss ratio of 81.5% to 82.5% and an SG&A expense ratio of 15.6% to 16.1%, both improved from previous guidance.
Total revenue guidance for full-year 2026 remains unchanged at $18.7 billion to $19.0 billion.
Key risks
Oscar Health’s business, financial condition, and results of operations could be harmed if it fails to execute its strategy and manage growth effectively, including challenges in acquiring new members, retaining existing members, expanding into new markets, or integrating acquisitions, which could result in significant expenses and regulatory hurdles.
The company’s success depends on retaining and expanding its member base, and factors such as regulatory changes, loss of broker relationships, inability to maintain competitive provider networks, or changes to government subsidies (like APTCs) could negatively impact membership, revenue, and profitability.
Failure to accurately estimate incurred medical expenses, overall market morbidity, or effectively manage medical and administrative costs could negatively affect Oscar Health’s financial position, results of operations, and cash flows, especially given uncertainties in regulatory changes, market dynamics, and risk adjustment programs.
Oscar Health is highly dependent on the regulatory environment created by the Affordable Care Act (ACA), and any significant changes, repeal, or adverse judicial interpretations of the ACA or related subsidies could materially and adversely affect its business, results of operations, and financial condition.
AI summary of the company's filings, every number checked against them · 8 October 2026 · Sources: earnings release, 10-K, 10-Q
Earnings alerts
An email when Oscar Health reports, with its results and highlights. Free with a watchlist account.
I
Value
●●●●●●2/6
Expensive against its own history and its sector: the price asks a lot of the business.
15.2xno history
0.6xown 5-year median 0.4x
44.5%cash earned per $ of price
2.6xwhole-business multiple
What does “Value” actually mean?
Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.
no positive three-year earnings growth behind the price
II
Growth
●●●●●●5/6
The business is growing, and consistently: revenue +42.8% in the last year.
+42.8%vs the year before
+43.5%compound annual
-net income growth
-compound annual
Revenue history
Is OSCR's revenue growing?
◌ dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
Period
Revenue ($)
Q1 2020
88.1M
Q2 2020
115.3M
Q3 2020
101.7M
Q4 2020
157.7M
Q1 2021
369.4M
Q2 2021
529.3M
Q3 2021
444.0M
Q4 2021
496.1M
Q1 2022
972.8M
Q2 2022
1.02B
Q3 2022
978.4M
Q4 2022
995.1M
Q1 2023
1.47B
Q2 2023
1.52B
Q3 2023
1.44B
Q4 2023
1.43B
Q1 2024
2.14B
Q2 2024
2.22B
Q3 2024
2.42B
Q4 2024
2.39B
Q1 2025
3.05B
Q2 2025
2.86B
Q3 2025
2.99B
Q4 2025
2.81B
Q1 2026
4.65B
Q2 2026
4.88B
2019
488.2M
2020
462.8M
2021
1.84B
2022
3.96B
2023
5.86B
2024
9.18B
2025
11.70B
→Revenue reached $11.7B in 2025, compounding +43% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $15.3B, ahead of the last full year.
What this measures
The money customers paid, before any costs are taken out. Each bar is one quarter or, on the annual view, a full financial year; the last annual bar may be the trailing twelve months, which the footnote marks.
What good looks like. Growth that repeats, rather than one strong year carrying the chart, and a trailing twelve months keeping pace with the last full year.
If it rises or falls. Revenue is the hardest line to flatter, so a rise is the most trustworthy kind of growth. A fall puts pressure on every margin below it, because costs rarely come down as quickly as sales do.
Profit history
Is OSCR's net profit growing?
◌ dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
Period
Net income ($)
Q1 2020
-96.9M
Q2 2020
-40.9M
Q3 2020
-79.1M
Q4 2020
-189.9M
Q1 2021
-88.9M
Q2 2021
-73.3M
Q3 2021
-211.5M
Q4 2021
-198.9M
Q1 2022
-75.2M
Q2 2022
-112.2M
Q3 2022
-192.9M
Q4 2022
-226.0M
Q1 2023
-39.8M
Q2 2023
-15.5M
Q3 2023
-65.4M
Q4 2023
-150.0M
Q1 2024
177.4M
Q2 2024
56.2M
Q3 2024
-54.6M
Q4 2024
-153.5M
Q1 2025
275.3M
Q2 2025
-228.4M
Q3 2025
-137.4M
Q4 2025
-352.6M
Q1 2026
679.0M
Q2 2026
361.8M
2019
-261.2M
2020
-406.8M
2021
-572.6M
2022
-606.3M
2023
-270.7M
2024
25.4M
2025
-443.2M
→2025 closed with a loss of $443M after being profitable the year before. One bad year is not a pattern, but it is what the balance sheet has to absorb.
What this measures
What is left after every cost, including tax and interest. The bottom line of the income statement.
What good looks like. Profit growing at least as fast as revenue, which means the business is keeping more of each sale as it gets bigger.
If it rises or falls. Profit can move for reasons revenue cannot explain - a one-off charge, a tax change, a write-down - so a single sharp year is worth checking against the margin chart before reading it as a trend.
Growth rate
How fast are OSCR's revenue and earnings growing?
Shown separately because they would flatten the axis: 2025 earnings -1842% - rebounds off a collapsed prior year.
Year
Revenue growth
Earnings growth
2,020
-0.052
-
2,021
2.973
-
2,022
1.1557
-
2,023
0.4792
-
2,024
0.5654
-
2,025
0.275
-
2026
0.4282
-
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly views, growth is the trailing twelve months against the twelve before, or a quarter against the same quarter a year earlier
→Revenue grew 43% over the twelve months to 2026-06-30, against an average of +109% a year over 2021-2025.
What this measures
How much revenue and earnings changed against the year before - the trailing twelve months against the twelve before them at each quarter, or one point per fiscal year. It is the speed of the business, not its size.
What good looks like. The earnings line above the revenue line: profits growing faster than sales means each new dollar of sales arrives more profitably than the last.
If it rises or falls. A high growth rate off a small base is easy and gets harder every year, so slowing growth in a large business is normal rather than a warning. Earnings falling while revenue grows is the combination worth understanding: costs are rising faster than sales.
Per-share growth
Are OSCR's revenue and free cash flow per share growing?
Year
Revenue per share ($)
Free cash flow per share ($)
2,019
16.9432
-
2,020
15.815
-
2,021
10.274
-
2,022
18.6546
-
2,023
26.4504
-
2,024
34.5212
-
2,025
44.5959
-
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Revenue per share reached $44.60 in 2025, compounding +34% a year against +43% for OSCR as a whole. Dilution absorbed about 9.7 points of that growth. The trailing twelve months are running at $58.38 a share.
What this measures
Revenue and free cash flow, each divided by the number of shares in issue and adjusted for splits so old and new years compare honestly. Both lines rising means each share owns more of the business's sales and cash.
What good looks like. Both lines rising, and revenue per share growing at least as fast as the company's total revenue, which the answer compares. Faster means buybacks are working for you; slower means new shares are absorbing part of the growth.
If it rises or falls. This is the line that actually reaches you. A company can grow revenue every year and still shrink your slice by issuing shares faster than it grows.
What does “Growth” actually mean?
Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).
A solidly profitable business, though not exceptional against its sector.
-kept after direct costs
4.1%kept after running costs
40.0%profit on shareholders' money
4.9%profit on everything it owns
802%operating cash ÷ net income
Margins
What profit margin does OSCR keep on each sale?
Year
Gross
Operating
Net
2,019
-
-0.5313
-0.535
2,020
-
-0.8692
-0.879
2,021
-
-0.2961
-0.3114
2,022
-
-0.1488
-0.153
2,023
-
-0.0402
-0.0462
2,024
-
0.0062
0.0028
2,025
-
-0.0339
-0.0379
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Operating margin widened 11 points to -3% since 2022. The bottom line is still negative: costs below the operating line eat what is left. OSCR doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.
What this measures
What survives at three points on the way down the income statement: after the direct cost of the product, after the cost of running the company, and after everything.
What good looks like. Margins that hold or widen as the business grows. The level itself varies enormously by industry, so the shape over time tells you more than the number.
If it rises or falls. A widening margin means pricing power or costs under control. A compressing one means the opposite, and it compounds: on large revenue, two points of margin is a great deal of profit.
Earnings quality
Does OSCR's operating cash flow keep up with its profit?
Year
Cash from operations
Net income
2,019
-165.4M
-261.2M
2,020
222.7M
-406.8M
2,021
-181.7M
-572.6M
2,022
380.3M
-606.3M
2,023
-272.2M
-270.7M
2,024
978.2M
25.4M
2,025
1.09B
-443.2M
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Operating cash flow runs at 802% of reported profit, so the earnings are more than backed by cash - depreciation and other non-cash charges are understating what the business actually collects.
What this measures
Reported profit against the cash the business actually collected from operating. Profit is an accounting judgement; cash is not.
What good looks like. Cash at or above profit, year after year. Depreciation and other non-cash charges usually push cash above profit, so roughly 100% or more is healthy.
If it rises or falls. Cash falling behind profit for more than a year is the classic early warning: the sales are booked but the money has not arrived, and it shows up in receivables and inventory. For a lender the comparison behaves differently, because a growing loan book consumes cash.
Returns on capital
What return on equity and on capital does OSCR earn?
Year
ROE
ROA
ROCE
2,022
-0.5324
-0.1339
-0.4672
2,023
-0.3196
-0.0752
-0.201
2,024
0.028
0.0053
0.0416
2,025
-0.4451
-0.0701
-0.271
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→ROE of 40% and ROCE of 25% sit close together, so the returns come from the business itself rather than from borrowing.
What this measures
Two returns side by side: on shareholders' capital (ROE), and on all the capital in the business including debt (ROCE).
What good looks like. Both comfortably above roughly 10%, and close together. A wide gap means borrowing, not operations, is doing the work.
If it rises or falls. A high ROE built on debt looks like quality until the debt has to be refinanced. ROCE is the harder number to flatter, which is why both are shown.
Return on equity
Is OSCR's return on capital above what its capital costs?
Period
Return on equity
2022
-0.5324
2023
-0.3196
2024
0.028
2025
-0.4451
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→OSCR's return on equity is negative at -44.5% in 2025. The capital in the business is not yet earning anything back.
What this measures
The same return as the card above, but every filed year, against a 10% line that stands in for what capital costs.
What good looks like. Years above the line, and a trend that is flat or rising rather than drifting down towards it.
If it rises or falls. A business earning above its cost of capital creates value by growing; one earning below it destroys value by growing. The 10% line is a convention, not a law, so read the distance from it rather than the crossing.
What does “Quality” actually mean?
Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.
Financially sound overall, with one or two things worth watching.
0.21xborrowed vs owned
1.1xnear-term bills coverage
40xearnings ÷ interest bill
$8.6Bcash plus short-term investments
Debt & cash
How much debt does OSCR carry, and do its profits cover the interest?
Year
Total debt
Cash & investments
2,019
-
336.6M
2,020
142.5M
1.19B
2,021
0
1.69B
2,022
298.0M
2.96B
2,023
298.8M
2.56B
2,024
299.6M
2.15B
2,025
430.1M
3.99B
2,026
431.6M
8.56B
◌ each quarterly point is the balance sheet at that quarter end
→The company holds $8.6B in cash against $432M of debt - a net-cash balance sheet, which means a bad year is an inconvenience rather than a threat.
What this measures
Total borrowings against cash on hand, with debt as a multiple of shareholders' equity, and how many times profit covers the interest bill.
What good looks like. Interest covered comfortably - roughly eight times or more - and debt that is not a large multiple of equity.
If it rises or falls. Debt is only a problem when it has to be repaid or refinanced in a bad year, so cover matters more than the amount. Rising debt with rising cover is a business borrowing to grow; rising debt with falling cover is the combination that ends badly.
Near-term liquidity
Do OSCR's current assets cover the bills due within a year?
Period
Current ratio
2020
1.123
2021
1.2449
2022
1.2628
2023
1.2602
2024
0.8215
2025
0.9488
◌ 2026 = the latest balance sheet (2026-06-30), not a fiscal year-end · each quarterly point is the balance sheet at that quarter end
→Near-term liquidity is adequate but not generous: 1.1x of current assets against a dollar due within the year. That is much the same than in 2020.
What this measures
Current assets over current liabilities: what the company can turn into cash within a year against what it owes within a year.
What good looks like. Comfortably above 1.0, and not falling year after year. Below 1.0 means near-term bills exceed near-term resources, which is normal for some business models and a warning in others.
If it rises or falls. Inventory and receivables build it up; short-term borrowing and payables pull it down. A retailer that turns stock over quickly can run lower than a manufacturer and be perfectly sound.
Interest cover
How many times over can OSCR's operating profit pay its interest bill?
Period
Interest cover (x)
2020
-114.4752
2021
-115.3561
2022
-26.0738
2023
-9.5767
2024
2.4128
2025
-22.519
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Interest is a rounding error against profit: 39.7x cover. Cover is wider than in 2020.
What this measures
Operating profit divided by interest expense - how many times over the year's earnings could pay the year's interest.
What good looks like. High and steady. Five times is a common floor; comfortably above it means the debt is being carried, not merely serviced.
If it rises or falls. It falls when profit falls or when borrowing costs rise, and a company can look safe on the level while the direction is telling you otherwise.
Cash conversion
How much of OSCR's revenue arrives as operating cash?
Period
Operating cash flow / revenue
2019
-0.3387
2020
0.4813
2021
-0.0988
2022
0.096
2023
-0.0464
2024
0.1066
2025
0.0936
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→28.8% of every dollar OSCR sold arrived as operating cash. Up from -33.9% in 2019.
What this measures
Operating cash flow as a share of revenue: of every dollar sold, how much reached the bank before capital spending.
What good looks like. A high share, holding up or improving. It is the clearest sign that reported profit is real.
If it rises or falls. It falls when customers take longer to pay or stock builds up, and it can stay high while profit falls - which is usually the more reassuring of the two.
Shareholders' equity
Is OSCR's shareholder equity (book value) growing?
Period
Equity ($)
2019
-945.1M
2020
-1.30B
2021
1.39B
2022
890.4M
2023
804.0M
2024
1.01B
2025
977.6M
2026
2.05B
→The company's own capital grew from $804M in 2023 to $2.1B (+155%). The business is building book value rather than consuming it.
What this measures
What would be left for shareholders if every asset were sold at its book value and every debt repaid. Book value, in other words.
What good looks like. Equity growing as retained profits build up, unless the company is deliberately returning more than it earns.
If it rises or falls. Equity falls for two very different reasons: buybacks, which return money to you, and losses, which do not. The distinction is the whole story, and negative equity means liabilities now exceed assets, which makes debt-to-equity and return on equity meaningless rather than alarming.
What does “Health” actually mean?
Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.
OSCR returns nothing to shareholders yet, and the share count keeps rising. Every dollar stays in the business.
+0.00%bought back, TTM, over market value
-at the current rate
$0.00dividends plus buybacks
$75Mlast 12m, dilutes the buybacks
+922.1%since 2019 (split-adjusted)
Capital returned vs stock comp
Do OSCR's buybacks and dividends outweigh the stock it issues to staff?
Year
Buybacks
Dividends
Stock comp
2,019
3.0M
-
33.6M
2,020
-
-
35.9M
2,021
-
-
86.3M
→OSCR returned no cash to shareholders in the latest filed year: everything is being retained or reinvested.
What this measures
Cash returned through buybacks and dividends, alongside the value of new shares issued to employees as compensation.
What good looks like. Returns comfortably larger than stock compensation, so the share count actually falls.
If it rises or falls. A company can announce billions in buybacks while issuing nearly as much stock to staff, and the two largely cancel. What reaches you is the net effect, which is why both bars are here rather than only the buyback.
Share count change (split-adjusted)
Is OSCR's share count rising or falling?
Year
Share-count change
2,020
0.0156
2,021
5.1157
2,022
0.1872
2,023
0.0432
2,024
0.1994
2,025
-0.013
→The share count shrank 1.3% in 2025. Buybacks are concentrating your ownership: the same business, split fewer ways.
What this measures
The yearly change in the number of shares in issue, adjusted for splits so the years compare. A bar below zero is a falling share count, usually from buybacks; above zero, new shares were issued.
What good looks like. A flat or falling share count. Falling means each share you hold owns a little more of the business every year.
If it rises or falls. A rising count divides the same business among more owners, so your slice shrinks unless profits grow faster. This is the most direct chart on the page: it is your ownership, measured.
Dilution against what it bought
Has OSCR's revenue per share grown faster than its share count?
Change since 2019. The gap between the lines is what each share gained or lost. Share counts are split-adjusted weighted averages.
Year
Share count, change since 2019
Revenue per share, change since 2019
2,019
0
0
2,020
0.0156
-0.0666
2,021
5.2113
-0.3936
2,022
6.3742
0.101
2,023
6.6928
0.5611
2,024
8.2268
1.0375
2,025
8.1065
1.6321
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly view, revenue per share is the trailing twelve months over that quarter's diluted count
→OSCR's share count rose 811% from 2019 to 2025 while revenue per share grew 163%. Holders are further ahead than before, though the gain per share is smaller than the growth in the business.
What this measures
The share count and revenue per share over the same years, both indexed to 100 at the start, so the two lines can be compared directly.
What good looks like. The per-share line above the share-count line: whatever the company did with its shares, more business ended up behind each one.
If it rises or falls. Issuing shares is not automatically bad. It is bad when the money raised buys less growth than the dilution cost, which is exactly what the gap between these two lines shows.
Why compare buybacks with stock compensation?
A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.
→OSCR is in a clear uptrend: the price is above the cloud where recent trading settled, and that cloud is still rising underneath it. The last two weeks have turned up, but the price is still below where it stood a month ago.
How the trend above is worked out
The trend read is the daily Ichimoku picture, the same indicator drawn on the chart above. Five names, and what each one is: the TENKAN is the midpoint of the last 9 sessions' high and low, the fast line; the KIJUN is the same over 26 sessions, the slow one; the two SENKOU spans are midpoints drawn 26 sessions into the FUTURE, and the band between them is the KUMO cloud - because it is drawn forward, the support for the coming weeks is already fixed and a change of its direction can be seen coming; the CHIKOU is today's close compared with the close 26 sessions back. A trend confirms itself in that order and the checks follow it: price clears the cloud, holds above both lines, the Tenkan crosses above the Kijun, the cloud ahead turns up, and the Chikou stands higher than the price a month ago. Six of six therefore means all of that at once; a price sitting inside the cloud, or below its own lines, cannot get there. The last check is the one Ichimoku cannot answer - whether the S&P 500 did better over 12 months (252 sessions), measured on the SPY ETF with dividends included, on the same adjusted basis as the stock's own price. Our figures are the last close we hold, refreshed every trading night; the chart is live. None of this says anything about the business, and it is not advice.
Are OSCR's insiders buying or selling shares with their own money?
Month
Buys ($)
Sells ($)
2023-11
0
2.8M
2023-12
0
891,725
2024-01
0
0
2024-02
0
1.8M
2024-03
0
1.8M
2024-04
0
0
2024-05
0
0
2024-06
0
2.9M
2024-07
0
0
2024-08
0
0
2024-09
0
7.6M
2024-10
0
0
2024-11
46.1M
426,250
2024-12
0
2.7M
2025-01
0
0
2025-02
0
0
2025-03
0
0
2025-04
0
0
2025-05
0
410,750
2025-06
0
0
2025-07
0
0
2025-08
0
0
2025-09
0
7.3M
2025-10
0
0
2025-11
0
6.0M
2025-12
0
1.6M
2026-01
0
5.3M
2026-02
0
0
2026-03
0
995,640
2026-04
11.9M
0
2026-05
0
5.1M
2026-06
0
102.8M
2026-07
0
1.5M
2026-08
0
23.4M
2026-09
0
3.3M
2026-10
0
0
→Since November 2023, insiders bought $58M and sold $178M on the open market, a net sale of $120M. A further 176 transactions were grants, option exercises or tax withholding, which say nothing either way.
What this measures
Open-market buys and sells by the company's own officers and directors, from their Form 4 filings. Grants, option exercises and shares withheld for tax are excluded, because they are compensation rather than decisions.
What good looks like. Buying with their own money, which is the one insider action that is hard to explain away.
If it rises or falls. Selling is weak evidence: insiders sell to diversify, to buy houses, and on pre-scheduled plans set months ahead. Buying is stronger evidence, because there is only one reason to do it. The absence of any buying over a long stretch is itself worth noticing.
The record
Who did what, exactly?
Date
Insider
Role
Type
Shares
Price
Value
2026-09-18
Vanessa Ames Wittman
Director
SELL
25,000
$32.24
$806,000
2026-09-03
Janet Liang
President, Oscar Insurance
SELL
10,360
$31.45
$325,822
2026-09-03
Victoria Baltrus
Chief Accounting Officer
SELL
958
$31.45
$30,129
2026-09-03
Richard Scott Blackley
Chief Financial Officer
SELL
28,869
$31.45
$907,930
2026-09-03
Adam Mcananey
Chief Legal Officer
SELL
9,092
$31.45
$285,943
2026-09-03
Mario Schlosser
Director
SELL
31,422
$31.45
$988,222
2026-08-28
Mario Schlosser
Director
SELL
150,000
$30.79
$4.62M
2026-08-27
Mario Schlosser
Director
SELL
600,000
$30.34
$18.2M
2026-08-18
Richard Scott Blackley
Chief Financial Officer
SELL
18,750
$31.74
$595,125
2026-07-01
Mario Schlosser
Director
SELL
3,600
$29.50
$106,200
2026-07-01
Mario Schlosser
Director
SELL
13,672
$30.80
$421,098
2026-07-01
Mario Schlosser
Director
SELL
30,228
$31.65
$956,716
2026-06-30
Mark T Bertolini
Chief Executive Officer
SELL
488,654
$28.35
$13.85M
2026-06-30
Mark T Bertolini
Chief Executive Officer
SELL
135,590
$28.97
$3.93M
2026-06-29
Mark T Bertolini
Chief Executive Officer
SELL
555,826
$29.17
$16.21M
2026-06-29
Mark T Bertolini
Chief Executive Officer
SELL
58,926
$30.08
$1.77M
2026-06-26
Mark T Bertolini
Chief Executive Officer
SELL
441,373
$29.11
$12.85M
2026-06-26
Mark T Bertolini
Chief Executive Officer
SELL
149,795
$29.79
$4.46M
2026-06-25
Mark T Bertolini
Chief Executive Officer
SELL
597,942
$28.60
$17.1M
2026-06-25
Mark T Bertolini
Chief Executive Officer
SELL
17,200
$29.08
$500,176
2026-06-23
Mario Schlosser
Director
SELL
286,988
$28.95
$8.31M
2026-06-23
Mario Schlosser
Director
SELL
591,213
$29.58
$17.49M
2026-06-23
Mario Schlosser
Director
SELL
1,799
$30.09
$54,132
2026-06-23
Mario Schlosser
Director
SELL
16,307
$28.95
$472,088
2026-06-23
Mario Schlosser
Director
SELL
33,591
$29.58
$993,622
2026-06-23
Mario Schlosser
Director
SELL
102
$30.09
$3,069
2026-06-23
Mario Schlosser
Director
SELL
16,306
$28.95
$472,059
2026-06-23
Mario Schlosser
Director
SELL
33,592
$29.58
$993,651
2026-06-23
Mario Schlosser
Director
SELL
102
$30.09
$3,069
2026-06-23
Mario Schlosser
Director
SELL
15,491
$28.95
$448,464
2026-06-23
Mario Schlosser
Director
SELL
31,912
$29.58
$943,957
2026-06-23
Mario Schlosser
Director
SELL
97
$30.09
$2,919
Why do the transaction types matter so much?
Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.
VIII
Ownership
informational
64.7%on Form 13F, 30 June 2026
16.9%officers, directors, founders
42.2%together
Top holders
Who owns Oscar Health stock?
Fund managers filing Form 13F held 64.7% of the company's shares on 30 June 2026. The largest holder is Joshua Kushner and Thrive Partners II GP, LLC, with 10.6%. Insiders hold 16.9%.
#
Holder
Stake
Shares
Value
Change
1
Joshua Kushner and Thrive Partners II GP, LLCCo-Founder and Vice Chairman · Form 4, 18 September 2026
10.65%
32.9M
$1.0B
-
2
BlackRock, Inc.Fund manager
6.67%
20.6M
$657M
+18.9%
3
T. Rowe Price Investment Management, Inc.Fund manager
4.22%
13.0M
$416M
+11.9%
4
D. E. Shaw & Co., Inc.Fund manager
4.10%
12.6M
$403M
+130.5%
5
Vanguard Portfolio Management LLCFund manager
3.57%
11.0M
$352M
+4.6%
6
Vanguard Capital Management LLCFund manager
3.43%
10.6M
$337M
-1.8%
7
American Century Companies IncFund manager
2.93%
9.1M
$289M
+28.8%
8
Mark T BertoliniChief Executive Officer · Form 4, 29 June 2026
2.51%
7.8M
$247M
-
9
Jane Street Group, LLCFund manager
2.06%
6.4M
$203M
+119.2%
10
Thrive Capital Management, LLC and Thrive Partners VII Growth GP, LLCDirector · Form 4, 20 November 2024
2.06%
6.3M
$202M
-
11
Geode Capital Management, LLCFund manager
1.89%
5.8M
$186M
+15.6%
12
State Street CorpFund manager
1.88%
5.8M
$185M
+10.2%
13
FMR LLCFund manager
1.62%
5.0M
$159M
+317.0%
14
Citadel Advisors LLCFund manager
1.37%
4.2M
$135M
+22.0%
15
Two Sigma Investments, LPFund manager
1.31%
4.0M
$129M
+71.8%
16
Dimensional Fund Advisors LPFund manager
1.16%
3.6M
$114M
-14.8%
17
BIT Capital GmbHFund manager
1.11%
3.4M
$109M
-45.9%
18
Renaissance Technologies LLCFund manager
1.06%
3.3M
$105M
New
19
Price T Rowe Associates IncFund manager
1.05%
3.3M
$104M
+70.1%
20
Jacobs Levy Equity Management, IncFund manager
0.98%
3.0M
$96M
+22.3%
The full list of top holders is free with an account
Source: SEC Form 13F filings for the quarter to 30 June 2026, Schedules 13D and 13G, and Form 4. Shares on today's basis, value at the latest price.
Where does this list come from?
Fund managers with more than $100 million in US stocks report their holdings every quarter on Form 13F, up to 45 days after the quarter ends, so the fund figures are as of the last quarter end. A fund family reports as one manager, and funds together can report more than 100%: shares lent to short sellers are bought again by other funds, and both report them. Anyone holding more than 5% of a class files a Schedule 13D or 13G, and officers and directors report what they hold on Form 4 after every trade, so those rows carry their own dates. Short positions are not reported anywhere. A stake is the holder's shares as a share of all the company's shares, with other share classes converted at their market value.